Asimov

Asimov is a synthetic biology company building an integrated platform for the intelligent design of living systems. Its Edge Systems (CHO for biologics, LV for cell therapies, AAV for gene therapies, and RNA for RNA medicines) combine engineered mammalian host cells, a library of more than 1,000 validated genetic parts, and cloud-based genetic design software so biopharma partners can design and manufacture advanced therapeutics at higher titers and on faster timelines. Backed by a16z, DCVC, Wing Venture Capital, and Y Combinator. Added to the API Evangelist network as a company profile; no public developer API is currently published.

Asimov is profiled on the APIs.io network. Tagged areas include Company, Synthetic Biology, Biotechnology, Genetic Design, and Cell Line Development.

Asimov’s developer surface includes engineering blog, support, and 7 more developer resources.

🌐 Visit website 📡 Source on GitHub

15.6/100 emerging ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanySynthetic BiologyBiotechnologyGenetic DesignCell Line DevelopmentGene TherapyBioinformaticsLife Sciences

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 15.6/100 · emerging

Contract Quality 0.0 / 25

Developer Ergonomics 1.3 / 20

Commercial Clarity 4.2 / 20

Operational Transparency 0.7 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/asimov: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Agent Surfaces 1

MCP servers, agent skills, and machine-readable catalogs

LLMsTxt

LLMsTxt

Build 1

SDKs, sample code, and the tooling you integrate with

GitHubOrganization

GitHubOrganization

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Support

Support

Commercial 2

Pricing, plans, and the legal terms of use

TermsOfService

TermsOfService

PrivacyPolicy

PrivacyPolicy

Company 3

The organization behind the API

Website

Website

About

About

Blog

Blog

Source (apis.yml)

aid: asimov
name: Asimov
description: Asimov is a synthetic biology company building an integrated platform for the intelligent design of living systems.
  Its Edge Systems (CHO for biologics, LV for cell therapies, AAV for gene therapies, and RNA for RNA medicines) combine engineered
  mammalian host cells, a library of more than 1,000 validated genetic parts, and cloud-based genetic design software so biopharma
  partners can design and manufacture advanced therapeutics at higher titers and on faster timelines. Backed by a16z, DCVC,
  Wing Venture Capital, and Y Combinator. Added to the API Evangelist network as a company profile; no public developer API
  is currently published.
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://cdn.prod.website-files.com/631b859f947c1b7ed923e161/6391ebb616c34d3dafef930c_2K-render-compressed-1.webp
url: https://raw.githubusercontent.com/api-evangelist/asimov/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- a16z
- dcvc
- wing-venture-capital
- y-combinator
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-18'
tags:
- Company
- Synthetic Biology
- Biotechnology
- Genetic Design
- Cell Line Development
- Gene Therapy
- Bioinformatics
- Life Sciences
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://www.asimov.com/
- type: About
  url: https://www.asimov.com/about
- type: Blog
  url: https://asimovbio.substack.com/
- type: Support
  url: https://www.asimov.com/contact
- type: GitHubOrganization
  url: https://github.com/asimovbio
- type: TermsOfService
  url: https://www.asimov.com/terms-of-service
- type: PrivacyPolicy
  url: https://www.asimov.com/privacy-policy
- type: DomainSecurity
  url: security/asimov-domain-security.yml
- type: LLMsTxt
  url: llms/asimov-llms.txt
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence